296 related articles for article (PubMed ID: 23543735)
1. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
[TBL] [Abstract][Full Text] [Related]
2. The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1.
Qiao L; Zhang Q; Zhang W; Chen JJ
J Cell Mol Med; 2018 Nov; 22(11):5333-5345. PubMed ID: 30079588
[TBL] [Abstract][Full Text] [Related]
3. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
4. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
[TBL] [Abstract][Full Text] [Related]
6. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression.
Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N
Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279
[TBL] [Abstract][Full Text] [Related]
7. The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.
Por E; Byun HJ; Lee EJ; Lim JH; Jung SY; Park I; Kim YM; Jeoung DI; Lee H
J Biol Chem; 2010 May; 285(19):14475-85. PubMed ID: 20220142
[TBL] [Abstract][Full Text] [Related]
8. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
9. The Histone Acetyltransferase GCN5 Expression Is Elevated and Regulated by c-Myc and E2F1 Transcription Factors in Human Colon Cancer.
Yin YW; Jin HJ; Zhao W; Gao B; Fang J; Wei J; Zhang DD; Zhang J; Fang D
Gene Expr; 2015; 16(4):187-96. PubMed ID: 26637399
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between AKAP95, cyclin E1, cyclin D1, and clinicopathological parameters in lung cancer tissue].
Hu SX; Kong XY; Yuan YY; Teng BG; Zhi XH; Zhuang WX; Yu XY; Liu WZ; Zhang YX
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Dec; 31(12):890-4. PubMed ID: 24370359
[TBL] [Abstract][Full Text] [Related]
11. GSK3β-dependent cyclin D1 and cyclin E1 degradation is indispensable for NVP-BEZ235 induced G0/G1 arrest in neuroblastoma cells.
Liu SL; Liu Z; Zhang LD; Zhu HQ; Guo JH; Zhao M; Wu YL; Liu F; Gao FH
Cell Cycle; 2017; 16(24):2386-2395. PubMed ID: 28980866
[TBL] [Abstract][Full Text] [Related]
12. A novel function of HRP-3 in regulating cell cycle progression via the HDAC-E2F1-Cyclin E pathway in lung cancer.
Yun HS; Lee J; Kim JY; Sim YJ; Lee CW; Park JK; Kim JS; Ahn J; Song JY; Baek JH; Hwang SG
Cancer Sci; 2022 Jan; 113(1):145-155. PubMed ID: 34714604
[TBL] [Abstract][Full Text] [Related]
13. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells.
Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G
Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731
[TBL] [Abstract][Full Text] [Related]
14. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
15. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
You W; Chen B; Liu X; Xue S; Qin H; Jiang H
Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1.
Pozner A; Terooatea TW; Buck-Koehntop BA
J Biol Chem; 2016 Nov; 291(47):24538-24550. PubMed ID: 27694442
[TBL] [Abstract][Full Text] [Related]
18. GCN-5/PGC-1α signaling is activated and associated with metabolism in cyclin E1-driven ovarian cancer.
Guo T; Li B; Gu C; Chen X; Han M; Liu X; Xu C
Aging (Albany NY); 2019 Jul; 11(14):4890-4899. PubMed ID: 31313989
[TBL] [Abstract][Full Text] [Related]
19. FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells.
Chang MM; Lai MS; Hong SY; Pan BS; Huang H; Yang SH; Wu CC; Sun HS; Chuang JI; Wang CY; Huang BM
Cancer Sci; 2018 Nov; 109(11):3503-3518. PubMed ID: 30191630
[TBL] [Abstract][Full Text] [Related]
20. p16( INK4a) positively regulates cyclin D1 and E2F1 through negative control of AUF1.
Al-Khalaf HH; Colak D; Al-Saif M; Al-Bakheet A; Hendrayani SF; Al-Yousef N; Kaya N; Khabar KS; Aboussekhra A
PLoS One; 2011; 6(7):e21111. PubMed ID: 21799732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
